Cipla bird flu drug defies Roche

17/10/2005 - Cipla announced plans on Friday that will see it become the first company to sell a generic version of the anti-influenza drug Tamiflu.

The company claimed it was already making generic Tamiflu (oseltamivir phosphate) and should have its first batch of 1,300 treatments on the market in early 2006.
Tamiflu, which reduces the severity and spread of traditional flu, is already in short supply throughout the world, as countries gather stockpiles of the drug amid fears of a possible avian flu epidemic.

link to full article from in-pharmatech

tamiflu